FIORINO, GIONATA
 Distribuzione geografica
Continente #
EU - Europa 1.910
NA - Nord America 1.849
AS - Asia 931
SA - Sud America 291
Continente sconosciuto - Info sul continente non disponibili 34
AF - Africa 25
OC - Oceania 3
Totale 5.043
Nazione #
US - Stati Uniti d'America 1.808
RU - Federazione Russa 927
SG - Singapore 437
SE - Svezia 316
CN - Cina 267
BR - Brasile 253
IE - Irlanda 234
DE - Germania 115
HK - Hong Kong 99
FR - Francia 82
GB - Regno Unito 65
UA - Ucraina 59
VN - Vietnam 50
IT - Italia 41
FI - Finlandia 37
AR - Argentina 17
CA - Canada 16
IN - India 11
BD - Bangladesh 9
IQ - Iraq 9
MX - Messico 8
TR - Turchia 8
ZA - Sudafrica 7
CO - Colombia 6
VE - Venezuela 6
BE - Belgio 5
ES - Italia 5
ID - Indonesia 5
JP - Giappone 5
EC - Ecuador 4
JM - Giamaica 4
KZ - Kazakistan 4
PH - Filippine 4
TN - Tunisia 4
CH - Svizzera 3
EG - Egitto 3
GT - Guatemala 3
MA - Marocco 3
NL - Olanda 3
PK - Pakistan 3
PL - Polonia 3
SC - Seychelles 3
AL - Albania 2
AM - Armenia 2
AU - Australia 2
AZ - Azerbaigian 2
CR - Costa Rica 2
DZ - Algeria 2
IL - Israele 2
JO - Giordania 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
NI - Nicaragua 2
NP - Nepal 2
PE - Perù 2
PR - Porto Rico 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
AO - Angola 1
AT - Austria 1
BG - Bulgaria 1
BW - Botswana 1
BY - Bielorussia 1
CL - Cile 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
EE - Estonia 1
GD - Grenada 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
KE - Kenya 1
KG - Kirghizistan 1
KW - Kuwait 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 5.010
Città #
Moscow 283
Chandler 280
Singapore 264
Dublin 234
Ashburn 223
Dallas 162
Nyköping 133
Jacksonville 128
Beijing 108
Hong Kong 99
San Jose 83
Council Bluffs 61
The Dalles 53
Dearborn 45
Los Angeles 40
Lancaster 39
Lauterbourg 39
Princeton 38
Medford 36
Cambridge 35
Des Moines 32
Boardman 28
Munich 26
Frankfurt am Main 19
Turku 19
São Paulo 18
Ann Arbor 17
Buffalo 16
Ho Chi Minh City 16
Belo Horizonte 15
Rio de Janeiro 14
Tianjin 14
Jinan 13
Shenyang 13
Orem 12
Santa Clara 11
Brooklyn 10
Guangzhou 10
Phoenix 10
Redondo Beach 10
San Mateo 9
Hanoi 8
New York 8
Helsinki 7
Chicago 6
Curitiba 6
Düsseldorf 6
London 6
Pozzuolo Martesana 6
Wilmington 6
Zhengzhou 6
Atlanta 5
Brasília 5
Brussels 5
Denver 5
Hebei 5
Johannesburg 5
Porto Alegre 5
Rome 5
Santo André 5
Washington 5
Bremen 4
Caracas 4
Da Nang 4
Kingston 4
Messina 4
Philadelphia 4
Shenzhen 4
Taizhou 4
Tokyo 4
Woodbridge 4
Biên Hòa 3
Bogotá 3
Boston 3
Cairo 3
Campinas 3
Canoas 3
Fuzhou 3
Guarulhos 3
Guatemala City 3
Haiphong 3
Hangzhou 3
Houston 3
Istanbul 3
Itajubá 3
João Pessoa 3
Lanzhou 3
Maceió 3
Manchester 3
Montreal 3
Nanchang 3
Stockholm 3
Vancouver 3
Amman 2
Aparecida de Goiânia 2
Aracaju 2
Austin 2
Baghdad 2
Baku 2
Barra Mansa 2
Totale 2.950
Nome #
Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: a prospective study. 182
Adalimumab in Crohn's Disease: Tips and Tricks After 5 Years of Clinical Experience 177
Response evaluation and safety of thiopurines in the treatment of inflammatory bowel diseases (IBD): safety and response evaluation. 169
A prospective comparison between CT enterography and MR enterography (MRE) in ileo-colonic Crohn’s disease: a single-center experience. 167
A Prospective Comparison Between Computerized Tomography (CT) and Magnetic Resonance (MR) in Ileo-Colonic Crohn's Disease: A Single-Center Experience. 164
Different Segmental Transit Time (TT) Through the Small Bowel May Affect Wireless Capsule (WC) Endoscopy 161
Late-onset Crohn's disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease 'AGED' study 156
Dual Targeted Therapy: a possible option for the management of refractory Inflammatory Bowel Disease 155
Balanced Propofol Sedation (BPS) Administered by Non-Anesthesiologists vs Midazolam Alone for Endoscopic Procedure in Patients With IBD: A Single Center Open-Label Trial 153
H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biologics. 153
The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy 149
Emerging biologics in the treatment of inflammatory bowel disease: what is around the corner? 148
Infliximab Inhibits Mucosal Pathological Angiogenesis in Crohn's Disease 145
Acute Severe Colitis: Infliximab and/or Cyclosporine? 144
Anti-TNF's for postoperative recurrence in Crohn's disease: the if's and how's. 142
Heat shock protein 47 is a new candidate molecule as anti-fibrotic treatment of Crohn's disease: authors' reply 142
Familial aggregation in inflammatory bowel disease: Is it genes or environment? 141
Adalimumab in ulcerative colitis: hypes and hopes 137
Anti-TNF Therapy in Inflammatory Bowel Diseases 135
A prospective comparison between 1.5T magnetic resonance and 3T magnetic resonance in ileo-colonic Crohn’s disease: a single center experience. 133
Comparison of two strategies for the management of postoperative recurrence in Crohn's disease patients with one clinical risk factor: A multicentre IG-IBD study 128
Biological Therapy for Ulcerative Colitis: what is after Anti-TNF. 126
Postoperative recurrence of Crohn's disease and videocapsule endoscopy: it is necessary to leave no stone unturned. 107
Leukocyte traffic control: a novel therapeutic strategy for inflammatory bowel disease 103
Videocapsule Endoscopy in Portal Hypertension 102
Review article: anti TNF-alpha induced psoriasis in patients with inflammatory bowel disease. 101
Review article: anti-fibrotic agents for the treatment of Crohn's disease - lessons learnt from other diseases. 100
Safety of a (H1N1)V Vaccine in patients with inflammatory bowel disease treated with immunomodulators and biologicals 100
Influenza A (H1N1)v infection in patients with inflammatory bowel disease: a case series. 100
Narrow-band imaging endoscopy to assess mucosal angiogenesis in inflammatory bowel disease: a pilot study. 96
Infliximab therapy inhibits inflammation-induced angiogenesis in the mucosa of patients with Crohn's disease. 96
The efficacy of shortening the dosing interval to once every six weeks in Crohn's patients losing response to maintenance dose of infliximab. 89
Risk of postoperative recurrence and postoperative management of Crohn's disease. 89
New drug delivery systems in inflammatory bowel disease: MMX and taylored delivery to the gut. 89
The bacterial sensor Triggering Receptor Expressed on Myeloid cells 2 (TREM-2) is a crucial pathogenic mediator in inflammatory bowel disease (IBD) 86
MRI in Crohn's disease-current and future clinical applications. 82
Review article: Causative factors and the clinical management of patients with Crohn's disease who lose response to anti-TNF-α therapy. 77
Mucosal healing in Ulcerative Colitis: Where do we Stand? 76
Follow-up evaluation and management of anemia in inflammatory bowel disease: A study by the Italian Group for Inflammatory Bowel Diseases (IG-IBD) 75
Use of biosimilars in inflammatory bowel disease: Statements of the Italian Group for Inflammatory Bowel Disease. 73
null 37
null 31
null 27
Totale 5.043
Categoria #
all - tutte 17.330
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.330


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022210 0 0 0 0 5 1 8 8 1 36 54 97
2022/2023797 73 71 42 102 50 80 15 34 308 10 8 4
2023/2024189 14 29 7 48 20 30 3 13 2 16 0 7
2024/2025729 5 6 25 49 26 28 24 135 204 40 51 136
2025/20262.091 54 158 125 84 158 552 269 294 241 90 23 43
2026/2027294 22 70 78 109 15 0 0 0 0 0 0 0
Totale 5.043